217 related articles for article (PubMed ID: 20064974)
1. Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma.
Fakhrudin N; Ladurner A; Atanasov AG; Heiss EH; Baumgartner L; Markt P; Schuster D; Ellmerer EP; Wolber G; Rollinger JM; Stuppner H; Dirsch VM
Mol Pharmacol; 2010 Apr; 77(4):559-66. PubMed ID: 20064974
[TBL] [Abstract][Full Text] [Related]
2. Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma.
Atanasov AG; Blunder M; Fakhrudin N; Liu X; Noha SM; Malainer C; Kramer MP; Cocic A; Kunert O; Schinkovitz A; Heiss EH; Schuster D; Dirsch VM; Bauer R
PLoS One; 2013; 8(4):e61755. PubMed ID: 23630612
[TBL] [Abstract][Full Text] [Related]
3. Honokiol: a non-adipogenic PPARγ agonist from nature.
Atanasov AG; Wang JN; Gu SP; Bu J; Kramer MP; Baumgartner L; Fakhrudin N; Ladurner A; Malainer C; Vuorinen A; Noha SM; Schwaiger S; Rollinger JM; Schuster D; Stuppner H; Dirsch VM; Heiss EH
Biochim Biophys Acta; 2013 Oct; 1830(10):4813-9. PubMed ID: 23811337
[TBL] [Abstract][Full Text] [Related]
4. Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites.
Schupp M; Lee LD; Frost N; Umbreen S; Schmidt B; Unger T; Kintscher U
Hypertension; 2006 Mar; 47(3):586-9. PubMed ID: 16365190
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
[TBL] [Abstract][Full Text] [Related]
6. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review.
Wang L; Waltenberger B; Pferschy-Wenzig EM; Blunder M; Liu X; Malainer C; Blazevic T; Schwaiger S; Rollinger JM; Heiss EH; Schuster D; Kopp B; Bauer R; Stuppner H; Dirsch VM; Atanasov AG
Biochem Pharmacol; 2014 Nov; 92(1):73-89. PubMed ID: 25083916
[TBL] [Abstract][Full Text] [Related]
7. MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema.
Gregoire FM; Zhang F; Clarke HJ; Gustafson TA; Sears DD; Favelyukis S; Lenhard J; Rentzeperis D; Clemens LE; Mu Y; Lavan BE
Mol Endocrinol; 2009 Jul; 23(7):975-88. PubMed ID: 19389808
[TBL] [Abstract][Full Text] [Related]
8. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.
Bouaboula M; Hilairet S; Marchand J; Fajas L; Le Fur G; Casellas P
Eur J Pharmacol; 2005 Jul; 517(3):174-81. PubMed ID: 15987634
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms regulating repression of haptoglobin production by peroxisome proliferator-activated receptor-gamma ligands in adipocytes.
Vernochet C; Davis KE; Scherer PE; Farmer SR
Endocrinology; 2010 Feb; 151(2):586-94. PubMed ID: 19952271
[TBL] [Abstract][Full Text] [Related]
10. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy.
Shrivastav S; Kino T; Cunningham T; Ichijo T; Schubert U; Heinklein P; Chrousos GP; Kopp JB
Mol Endocrinol; 2008 Feb; 22(2):234-47. PubMed ID: 17932108
[TBL] [Abstract][Full Text] [Related]
12. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.
Burgermeister E; Schnoebelen A; Flament A; Benz J; Stihle M; Gsell B; Rufer A; Ruf A; Kuhn B; Märki HP; Mizrahi J; Sebokova E; Niesor E; Meyer M
Mol Endocrinol; 2006 Apr; 20(4):809-30. PubMed ID: 16373399
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) γ partial agonists.
Kaserer T; Obermoser V; Weninger A; Gust R; Schuster D
Eur J Med Chem; 2016 Nov; 124():49-62. PubMed ID: 27560282
[TBL] [Abstract][Full Text] [Related]
14. Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds.
Porskjær Christensen L; Bahij El-Houri R
Molecules; 2018 Sep; 23(10):. PubMed ID: 30248999
[TBL] [Abstract][Full Text] [Related]
15. Perfluorooctanoic acid binds to peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation in 3T3-L1 adipocytes.
Yamamoto J; Yamane T; Oishi Y; Kobayashi-Hattori K
Biosci Biotechnol Biochem; 2015; 79(4):636-9. PubMed ID: 25516096
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.
Puhl AC; Milton FA; Cvoro A; Sieglaff DH; Campos JC; Bernardes A; Filgueira CS; Lindemann JL; Deng T; Neves FA; Polikarpov I; Webb P
Nucl Recept Signal; 2015; 13():e004. PubMed ID: 26445566
[TBL] [Abstract][Full Text] [Related]
17. Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes.
Tzameli I; Fang H; Ollero M; Shi H; Hamm JK; Kievit P; Hollenberg AN; Flier JS
J Biol Chem; 2004 Aug; 279(34):36093-102. PubMed ID: 15190061
[TBL] [Abstract][Full Text] [Related]
18. Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity.
Hallenborg P; Jørgensen C; Petersen RK; Feddersen S; Araujo P; Markt P; Langer T; Furstenberger G; Krieg P; Koppen A; Kalkhoven E; Madsen L; Kristiansen K
Mol Cell Biol; 2010 Aug; 30(16):4077-91. PubMed ID: 20530198
[TBL] [Abstract][Full Text] [Related]
19. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes.
Wang H; Qiang L; Farmer SR
Mol Cell Biol; 2008 Jan; 28(1):188-200. PubMed ID: 17954559
[TBL] [Abstract][Full Text] [Related]
20. Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation.
Takahashi N; Goto T; Taimatsu A; Egawa K; Katoh S; Kusudo T; Sakamoto T; Ohyane C; Lee JY; Kim YI; Uemura T; Hirai S; Kawada T
Biochem Biophys Res Commun; 2009 Dec; 390(4):1372-6. PubMed ID: 19891958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]